Rare diseases
Investigational molecules
Locations
Back to France478 clinical trials in Bron, France across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study of Lu AG13909 in Adults with Cushing's Disease to Evaluate Safety and Effectiveness
FranceStudy of ribociclib combined with hormone therapy for patients with early-stage hormone receptor-positive, HER2-negative breast cancer
FranceStudy of Vorasidenib for Patients with Residual or Recurrent Grade 2 Glioma with IDH1 or IDH2 Mutation
FranceStudy of Troriluzole and ADI-PEG-20 for Patients with Newly Diagnosed and Recurrent Glioblastoma
FranceStudy of Lecanemab (BAN2401) Treatment in People with Early Alzheimer's Disease: Testing Safety and Effectiveness Over 18 Months
FranceStudy on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke
FranceStudy Comparing Atogepant and Topiramate for Preventive Treatment in Adults with Migraine
FranceStudy on the Safety and Effectiveness of Furmonertinib vs. Platinum-Based Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer
FranceStudy on Upadacitinib for Children with Moderate to Severe Ulcerative Colitis
FranceStudy of Ixekizumab and Adalimumab for Children with Juvenile Idiopathic Arthritis, Including Enthesitis-related Arthritis and Juvenile Psoriatic Arthritis
FranceStudy of XPro1595 for Patients with Early Alzheimer's Disease and Inflammation Markers
FranceStudy on the Safety and Effects of Lutetium (177Lu) Vipivotide Tetraxetan in Patients with Advanced Prostate Cancer and Different Levels of Kidney Function
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on multiple sclerosis and Parkinson's disease, including advanced PET imaging studies and evaluation of novel therapeutic approaches.
Studies include neuroinflammation assessment and serotonergic receptor expression analysis.
Comprehensive research into glioblastoma treatment approaches, combining innovative therapies with standard protocols.
Integration of radiotherapy, chemotherapy, and novel therapeutic agents for improved patient outcomes.
Targeted research on rare conditions including Dravet Syndrome and Alagille syndrome, focusing on innovative therapeutic approaches.
Emphasis on developing effective treatments for previously undertreated rare conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
